Baby Food Market size is Expected to Surpass Around US$ 120 Billion by 2030

[150+ Pages Report] As per the latest Research and survey report issued by Precedence Research, the global baby food market was valued at around USD 73.88 billion in 2021 and is expected to register revenues worth USD 120 billion by the end of 2030, growing at an exceptional CAGR of approximately 5.54% between 2022 and 2030.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1710

Baby Food Market Report Scope

A recent study by Precedence Research on the baby food market offers a forecast for 2022 and 2030. The study analyzes crucial trends that are currently determining the growth of the baby food market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of baby food. The study also provides the dynamics that are responsible for influencing the future status of the baby food market over the forecast period.

A detailed assessment of the baby food market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the baby food market along with their product portfolio enhances the reliability of this comprehensive research study.

Competition Landscape

The report has engulfed a chapter on the global baby food market’s competitive landscape, which provides detailed analysis and insights on companies offering baby food. Profiles of key companies, along with a strategic overview of their M&A and expansion plans across geographies, have been delivered in this chapter. This chapter is priceless for report readers, as its enables them in gauging their growth potential in the market and implement key strategies for extending their market reach.

This chapter offers key recommendations for both new and existing market participants, enabling them to emerge sustainably and profitably. Intelligence on the market players has been delivered on the basis of their product overview, SWOT analysis, key developments, key financials and company overview. Occupancy of these market participants has been tracked by the report and portrayed via an intensity map.

Read Also@ Fruit and Vegetable Processing Market size is Expected to Surpass Around US$ 545 Billion by 2030

Some of the Prominent Players in the Baby Food Market Include:

• Nestlé (Gerber Products Company)
• Danone S.A.
• Reckitt Benckiser (Mead Johnson & Company, LLC)
• Abbott
• Feihe International Inc.
• Fries land Campina
• Bellamy’s Organic
• Kraft Heinz
• HiPP GmbH & Co. Vertrieb KG
• Perrigo
• Arla Food

Baby Food Market Segmentation

By Category

•  Organic
• Conventional

By Types

• Milk Formula
• Dried
• Ready-to-Feed
•  Other

By Distribution Channel

• Drugstores/ Pharmacies
• Supermarkets/Hypermarkets
• Convenience Store
• Online Channels
• Other Distribution Channels

By Ingredients

• Fats and Oils
• Lactose
• Protein
• Flour
• Flavour Enhancer
• Vitamins & Minerals
• Others

By Formulation

• Powder
• Liquid

By Health Benefit

• Brain & Eye Development
• Muscular Growth
• Bones & Teeth Development
• Blood Enhancement
• Nervous System
• Vascular System
• Body Energy
• Other

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Regional Analysis

The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2022 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.

The report provides in-depth segment analysis of the global baby food market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the baby food market.

The report includes country-wise and region-wise market size for the period 2022-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2022-2030.

Why should you invest in this report?

If you are aiming to enter the global baby food market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for baby food are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Health Benefit Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Baby Food Market 

5.1. COVID-19 Landscape: Baby Food Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Baby Food Market, By Category Type

8.1. Baby Food Market, by Category Type, 2022-2030

8.1.1. Organic

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Conventional

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Baby Food Market, By Types

9.1. Baby Food Market, by Types Type, 2022-2030

9.1.1. Milk Formula

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Dried

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Ready-to-Feed

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Baby Food Market, By Ingredients Type 

10.1. Baby Food Market, by Ingredients Type, 2022-2030

10.1.1. Fats and Oils

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Lactose

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Protein

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Flour

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Flavour Enhancer

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.6. Vitamins & Minerals

10.1.6.1. Market Revenue and Forecast (2017-2030)

10.1.7. Others

10.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Baby Food Market, By Formulation Type

11.1. Baby Food Market, by Formulation Type, 2022-2030

11.1.1. Powder

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Liquid

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Baby Food Market, By Distribution Channel

12.1. Baby Food Market, by Distribution Channel, 2022-2030

12.1.1. Drugstores/ Pharmacies

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Supermarkets/Hypermarkets

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Online Channels

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Convenience Store

12.1.4.1. Market Revenue and Forecast (2017-2030)

12.1.5. Others

12.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Baby Food Market, By Health Benefit

13.1. Baby Food Market, by Health Benefit Type, 2022-2030

13.1.1. Brain & Eye Development

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Muscular Growth

13.1.2.1. Market Revenue and Forecast (2017-2030)

13.1.3. Bones & Teeth Development

13.1.3.1. Market Revenue and Forecast (2017-2030)

13.1.4. Blood Enhancement

13.1.4.1. Market Revenue and Forecast (2017-2030)

13.1.5. Nervous System

13.1.5.1. Market Revenue and Forecast (2017-2030)

13.1.6. Vascular System

13.1.6.1. Market Revenue and Forecast (2017-2030)

13.1.7. Body Energy

13.1.7.1. Market Revenue and Forecast (2017-2030)

13.1.8. Others

13.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Baby Food  Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Category (2017-2030)

14.1.2. Market Revenue and Forecast, by Types (2017-2030)

14.1.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.1.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.1.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.1.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Category (2017-2030)

14.1.7.2. Market Revenue and Forecast, by Types (2017-2030)

14.1.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.1.7.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.1.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.1.8.1. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Category (2017-2030)

14.1.9.2. Market Revenue and Forecast, by Types (2017-2030)

14.1.9.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.1.9.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.1.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.1.11. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Category (2017-2030)

14.2.2. Market Revenue and Forecast, by Types (2017-2030)

14.2.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.2.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.2.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.2.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Category (2017-2030)

14.2.8.2. Market Revenue and Forecast, by Types (2017-2030)

14.2.8.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.2.9. Market Revenue and Forecast, by Formulation (2017-2030)

14.2.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.2.10.1. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Category (2017-2030)

14.2.11.2. Market Revenue and Forecast, by Types (2017-2030)

14.2.11.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.2.12. Market Revenue and Forecast, by Formulation (2017-2030)

14.2.13. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.2.14. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Category (2017-2030)

14.2.15.2. Market Revenue and Forecast, by Types (2017-2030)

14.2.15.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.2.15.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.2.16. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.2.16.1. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Category (2017-2030)

14.2.17.2. Market Revenue and Forecast, by Types (2017-2030)

14.2.17.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.2.17.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.2.18. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.2.18.1. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Category (2017-2030)

14.3.2. Market Revenue and Forecast, by Types (2017-2030)

14.3.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.3.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.3.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.3.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Category (2017-2030)

14.3.7.2. Market Revenue and Forecast, by Types (2017-2030)

14.3.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.3.7.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.3.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.3.9. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Category (2017-2030)

14.3.10.2. Market Revenue and Forecast, by Types (2017-2030)

14.3.10.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.3.10.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.3.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.3.11.1. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Category (2017-2030)

14.3.12.2. Market Revenue and Forecast, by Types (2017-2030)

14.3.12.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.3.12.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.3.12.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.3.12.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Category (2017-2030)

14.3.13.2. Market Revenue and Forecast, by Types (2017-2030)

14.3.13.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.3.13.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.3.13.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.3.13.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Category (2017-2030)

14.4.2. Market Revenue and Forecast, by Types (2017-2030)

14.4.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.4.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.4.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.4.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Category (2017-2030)

14.4.7.2. Market Revenue and Forecast, by Types (2017-2030)

14.4.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.4.7.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.4.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.4.9. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Category (2017-2030)

14.4.10.2. Market Revenue and Forecast, by Types (2017-2030)

14.4.10.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.4.10.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.4.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.4.12. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Category (2017-2030)

14.4.13.2. Market Revenue and Forecast, by Types (2017-2030)

14.4.13.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.4.13.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.4.13.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.4.13.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Category (2017-2030)

14.4.14.2. Market Revenue and Forecast, by Types (2017-2030)

14.4.14.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.4.14.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.4.14.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.4.14.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Category (2017-2030)

14.5.2. Market Revenue and Forecast, by Types (2017-2030)

14.5.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.5.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.5.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.5.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Category (2017-2030)

14.5.7.2. Market Revenue and Forecast, by Types (2017-2030)

14.5.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.5.7.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.5.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.5.8.1. Market Revenue and Forecast, by Health Benefit (2017-2030)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Category (2017-2030)

14.5.9.2. Market Revenue and Forecast, by Types (2017-2030)

14.5.9.3. Market Revenue and Forecast, by Ingredients (2017-2030)

14.5.9.4. Market Revenue and Forecast, by Formulation (2017-2030)

14.5.9.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

14.5.9.6. Market Revenue and Forecast, by Health Benefit (2017-2030)

Chapter 15. Company Profiles

15.1. Nestlé (Gerber Products Company)

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Danone S.A.

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Reckitt Benckiser (Mead Johnson & Company, LLC)

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Abbott

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Feihe International Inc.

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Fries land Campina

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Bellamy’s Organic

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Kraft Heinz

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. HiPP GmbH & Co. Vertrieb KG

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Perrigo

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

15.11. Arla Food

15.11.1. Company Overview

15.11.2. Product Offerings

15.11.3. Financial Performance

15.11.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1710

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com